No Data
H-share Announcements | Tianchen Holdings Subsidiary Signs MoU with Didi Electric to Establish Joint Venture for Developing Hong Kong's New Energy Charging and Battery-Swapping Network; Initial Phase to Build 10 Multi-Functional Battery-Swap Stations
V立志博-B (09887): LBL-047 prioritizes the clinical development of indications for Sjögren's syndrome, systemic lupus erythematosus, and dermatomyositis; 歌礼制药-B (01672) will present data from multiple projects at the 33rd European Congress on Obesity (ECO 2026).
Hong Kong Stock Movement | Ascletis Pharma-B (01672) rose over 3% in early trading as the company is set to present multiple project data at the ADA 2026 Annual Meeting.
Ascletis Pharma-B (01672) rose more than 3% in early trading. As of the time of writing, it was up 2.06%, trading at HKD 16.85 with a turnover of HKD 7.3672 million.
Ascletis Pharma-B (01672) to present multiple project data at the American Diabetes Association's 2026 Annual Scientific Meeting.
Ascletis Pharma-B (01672) announced that it will present multiple projects in poster format at the American Diabetes Association (ADA) 2026 Annual Scientific Sessions, scheduled to take place from June 5 to 8, 2026, in New Orleans, Louisiana. The presentations will include preclinical data on ASC39, a potent and selective oral small-molecule amylin receptor agonist for the treatment of obesity, which has been selected as a late-breaking poster.
ASCLETIS-B: Annual Report 2025
Sagimet Biosciences Shares Rise With Focus on Acne Treatment
Hong Kong Stock Movement | Ascletis Pharma-B (01672) Surged Over 4% in the Morning Session; Core Pipeline ASC30 to Initiate Phase III Registration Clinical Trial
Ascletis Pharma-B (01672) rose more than 4% in the morning session. As of press time, it gained 3.46%, trading at HKD 18.82, with a turnover of HKD 21.991 million.
Anivid : over priced...